News

For many of the almost 40 million people in the U.S. who live with diabetes, monitoring blood sugar levels multiple times a ...
A re you getting the most out of your Apple Watch, especially when it comes to the wearable's health features? With its many ...
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices ...
Explore the innovative smart insole that uses solar energy to monitor foot pressure and movement in real time.
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
The distinction between biological and chronological age is vital for risk assessment and interventions aimed at enhancing longevity and quality of life.
The optional sensor attaches to the base of the Breezhaler device and collects data on the use of the inhaler, sending data remotely to an app on a smartphone ... for oral diabetes and weight ...
A Northeastern University researcher has found a new way to help more people manage their condition—by training pharmacists ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
The International Diabetes Federation has recognised Type 5 diabetes. It affects lean, malnourished young adults, mainly in Asia and Africa. This diabetes results from chronic undernutrition.
The implantation of a novel inferior vena cava (IVC) sensor demonstrated promising safety and feasibility in patients with heart failure, with its measurements showing a strong correlation with ...